封面
市場調查報告書
商品編碼
1518461

靜脈輸液敷料市場- 按產品(半透明、透明)、類型(膠帶、非粘性敷料)、材料(聚氨酯、聚酯、棉、人造絲、矽膠、丙烯酸)、最終用途(醫院和診所、ASC) -全球預測(2024 - 2032)

IV Dressing Market - By Product (Translucent, Transparent), Type (Adhesive Tapes, Non-adherent Dressings), Material (Polyurethane, Polyester, Cotton, Rayon, Silicone, Acrylic), End-use (Hospitals & Clinics, ASCs) - Global Forecast (2024 - 2032)

出版日期: | 出版商: Global Market Insights Inc. | 英文 183 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在慢性病盛行率不斷上升的推動下,靜脈輸液敷料市場在 2024 年至 2032 年期間將錄得 5.5% 的複合年成長率。據 Physiopedia 稱,全球約有三分之一的成年人患有多種慢性病。糖尿病、心血管疾病和癌症等慢性疾病需要長期靜脈注射藥物傳遞和輸液治療。隨著全球人口老化和生活方式的變化,這些慢性疾病的發生率持續上升,推動了對有效傷口護理解決方案(包括靜脈敷料)的需求。這些敷料在維持導管插入部位周圍的無菌環境、預防感染和促進最佳癒合結果方面發揮著至關重要的作用。

在醫療保健支出增加和政府措施的推動下,人們越來越重視提高醫療保健的可近性和品質。這不僅將增加患者獲得醫療服務的機會,還將擴大未來幾年對靜脈敷料的需求。

靜脈注射敷料產業根據產品、類型、材料、最終用途和地區進行分類。

半透明靜脈注射敷料市場將在 2032 年之前實現穩定成長,因為其透明度可以輕鬆監控插入部位,而無需移除敷料。這有助於持續觀察導管插入部位是否有感染或皮膚刺激的跡象,促進早期介入並降低併發症的風險。半透明敷料還提供了針對外部污染物的屏障,同時允許醫療保健提供者在不破壞敷料的情況下評估靜脈注射部位,從而提高患者的舒適度並最佳化臨床工作流程。

到 2032 年,矽基靜脈敷料市場將獲得顯著的吸引力,因為它具有溫和的黏合特性,可以在應用或去除過程中固定敷料,而不會造成皮膚創傷。矽膠材質具有優異的透氣性和皮膚貼合性,降低浸漬風險並提高患者舒適度。這些敷料也非常耐用和防水,可提供長期佩戴並防止濕氣進入。矽膠靜脈注射敷料特別適合皮膚敏感或需要長時間靜脈注射治療的患者,確保固定牢固並最大限度地減少更換敷料的需要,從而降低醫療成本並提高效率。

在醫療保健支出增加、對先進傷口護理解決方案的認知不斷提高以及患者人數不斷增加的推動下,到 2032 年,亞太地區 IV 敷料行業規模將穩步成長。旨在提高醫療保健可近性和負擔能力的政府措施進一步支持該地區的市場成長。醫療設備的技術進步和創新醫療解決方案的日益採用也有助於亞太地區靜脈注射敷料市場的擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率上升
      • 靜脈敷料的技術進步
      • 外科手術數量不斷增加
      • 新興經濟體不斷成長的醫療保健產業
    • 產業陷阱與挑戰
      • 嚴格的監管場景
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 半透明
  • 透明的

第 6 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 膠帶
  • 非黏性敷料

第 7 章:市場估計與預測:按材料分類,2021 - 2032 年

  • 主要趨勢
  • 聚氨酯
  • 聚酯纖維
  • 棉布
  • 人造絲
  • 矽酮
  • 丙烯酸纖維

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 門診手術中心
  • 療養院
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • 3M Company
  • Cardinal Health, Inc.
  • Covalon Technologies Ltd.
  • DermaRite Industries, LLC.
  • DeRoyal Industries, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • McKesson Corporation
  • Medline Industries, LP.
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Richardson Healthcare, Inc.
  • Smith & Nephew plc
簡介目錄
Product Code: 9116

The IV Dressing Market will record 5.5% CAGR during 2024-2032, driven by the increasing prevalence of chronic diseases. According to Physiopedia, globally, around one-third of all adults are affected by multiple chronic conditions. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require long-term intravenous therapies for medication delivery and fluid administration. As the global population ages and lifestyles change, the incidence of these chronic diseases continues to rise, driving the demand for effective wound care solutions, including IV dressings. These dressings play a crucial role in maintaining sterile environments around catheter insertion sites, preventing infections, and facilitating optimal healing outcomes.

There is a growing emphasis on improving healthcare accessibility and quality, driven by increasing healthcare expenditure and government initiatives. This will not only enhance patient access to medical care but also expand the demand for IV dressings in the coming years.

The IV dressing industry is classified based on product, type, material, end-use, and region.

The translucent IV dressings segment will witness steady growth through 2032, due to the transparency, which allows for easy monitoring of the insertion site without the need for dressing removal. This facilitates continuous observation of the catheter insertion site for signs of infection or skin irritation, promoting early intervention and reducing the risk of complications. Translucent dressings also provide a barrier against external contaminants while allowing healthcare providers to assess the IV site without disrupting the dressing, thereby improving patient comfort, and optimizing clinical workflow.

Silicone-based IV dressings segment will gain notable traction through 2032, owing to the gentle adhesive properties, which secure the dressing without causing skin trauma during application or removal. Silicone material offers excellent breathability and conformability to the skin, reducing the risk of maceration and enhancing patient comfort. These dressings are also highly durable and waterproof, providing long-term wear time and protection against moisture ingress. Silicone IV dressings are particularly suitable for patients with sensitive skin or those requiring prolonged IV therapy, ensuring secure fixation and minimizing the need for dressing changes, thus reducing healthcare costs and improving efficiency.

Asia Pacific IV dressings industry size will grow at a steady pace through 2032, driven by increasing healthcare expenditure, rising awareness about advanced wound care solutions, and expanding patient population. The government initiatives aimed at improving healthcare accessibility and affordability are further supporting market growth in the region. Technological advancements in medical devices and increasing adoption of innovative healthcare solutions are also contributing to the expansion of the IV dressing market in Asia Pacific.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases
      • 3.2.1.2 Technological advancements in IV dressing
      • 3.2.1.3 Increasing number of surgical procedures
      • 3.2.1.4 Growing healthcare sector in emerging economies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Translucent
  • 5.3 Transparent

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Adhesive tapes
  • 6.3 Non-adherent dressings

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Polyurethane
  • 7.3 Polyester
  • 7.4 Cotton
  • 7.5 Rayon
  • 7.6 Silicone
  • 7.7 Acrylic

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Nursing homes
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 3M Company
  • 10.2 Cardinal Health, Inc.
  • 10.3 Covalon Technologies Ltd.
  • 10.4 DermaRite Industries, LLC.
  • 10.5 DeRoyal Industries, Inc.
  • 10.6 Lohmann & Rauscher GmbH & Co. KG
  • 10.7 McKesson Corporation
  • 10.8 Medline Industries, LP.
  • 10.9 Molnlycke Health Care AB
  • 10.10 Paul Hartmann AG
  • 10.11 Richardson Healthcare, Inc.
  • 10.12 Smith & Nephew plc